SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-044060
Filing Date
2021-08-12
Accepted
2021-08-12 17:21:14
Documents
64
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q avir-10q_20210630.htm   iXBRL 10-Q 2258700
2 EX-10.3 avir-ex103_131.htm EX-10.3 1100724
3 EX-31.1 avir-ex311_7.htm EX-31.1 19929
4 EX-31.2 avir-ex312_6.htm EX-31.2 19790
5 EX-32.1 avir-ex321_8.htm EX-32.1 9396
6 EX-32.2 avir-ex322_9.htm EX-32.2 9412
7 GRAPHIC gpaynuy3b1nt000001.jpg GRAPHIC 35847
  Complete submission text file 0001564590-21-044060.txt   6957707

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA avir-20210630.xsd EX-101.SCH 40483
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avir-20210630_cal.xml EX-101.CAL 33556
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avir-20210630_def.xml EX-101.DEF 84055
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE avir-20210630_lab.xml EX-101.LAB 273733
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avir-20210630_pre.xml EX-101.PRE 201925
13 EXTRACTED XBRL INSTANCE DOCUMENT avir-10q_20210630_htm.xml XML 680854
Mailing Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110
Business Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Filer) CIK: 0001593899 (see all company filings)

IRS No.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39661 | Film No.: 211168793
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences